Month: September 2021

Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker
0 Comments
Affirm Holdings Inc. is joining the ranks of fintech companies vying for “super-app” status as the company plans a series of feature introductions that will broaden its platform beyond buy-now pay-later capabilities. Fintech companies in the U.S. are increasingly trying to follow in the footsteps of Chinese players like Alipay, combining payments with a host
0 Comments
Investors, particularly individual investors, buy, sell, and trade stocks with a certain sense of security. If a corporation deceives its investors, there is an avenue through which to seek recompense. It wasn’t always the case that you could pursue some justice. Most of investing history is fraught with deceit, folly, and enough “irrational exuberance” to
0 Comments
In this article LCID MU SHW Micron Technology headquarters in Biose, Idaho, March 28, 2021. Jeremy Erickson | Bloomberg | Getty Images Check out the companies making headlines after the bell Tuesday: Sherwin-Williams — The paint company saw its stock fall 3% in extended trading after the company lowered its third-quarter sales guidance. “The persistent
0 Comments
Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more
0 Comments
By the end of 2022, Hyundai HYMTF, -1.74% expects to offer seven vehicles in a lineup it calls “everyday sports cars.” The Korean automaker is building its N brand — a subbrand that offers high-performance editions of its ordinary cars. Arguably the most important of the bunch is the 2022 Hyundai Elantra N—a track-tuned version of
0 Comments
72 The latest reading of the New York City Recovery Index out of a possible score of 100. New York City’s economic recovery index experienced a slight increase the week of Sept. 18, rising from an overall score of 71 to 72 after falling by as much as six points the week before. A partial
0 Comments
Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and
0 Comments
As you may be aware, some business combinations with special purpose acquisition companies (SPACs) have not gone well. But one exception — at least so far — is eFFECTOR Therapeutics (NASDAQ:EFTR) and EFTR stock. Source: Shutterstock This clinical-stage biotechnology firm focuses on selective translation regulation inhibitors (STRIs) in cancer. EFTR stock is currently up some
0 Comments